| Novo Nordisk Pharma AG - Rybelsus 3 mg, Tabletten |
| 67446 | | 01 | | Rybelsus 3 mg | | Tabletten | | A10BJ06 | | Semaglutide | | 24.03.2020 | | |
|
| Composition |
| semaglutidum 3 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum K 90, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Semaglutidum | 3 mg |
| | BAG: Active Agent | Dose |
|---|
| Semaglutidum | 3 mg |
| | | | Inactive agents | Dose |
|---|
| Cellulosum Microcristallinum | | | Magnesii Stearas | | | Natrii Salcaprozas | | | Povidonum K | 90 | | Pro Compresso | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 101.42 | 126.70 | B | SL | No |
|
